Neuroprotective Effects of Compound-23 in Parkinson's Disease and Stroke Models
Author Information
Author(s): Kitamura Yoshihisa, Watanabe Shotaro, Taguchi Masanobu, Takagi Kentaro, Kawata Takuya, Takahashi-Niki Kazuko, Yasui Hiroyuki, Maita Hiroshi, Iguchi-Ariga Sanae MM, Ariga Hiroyoshi
Primary Institution: Kyoto Pharmaceutical University
Hypothesis
Does compound-23 provide neuroprotective effects against oxidative stress-induced cell death in Parkinson's disease and stroke models?
Conclusion
Compound-23 shows neuroprotective effects by reducing oxidative stress and preventing dopaminergic cell death in Parkinson's disease and stroke models.
Supporting Evidence
- Comp-23 prevented oxidative stress-induced death of SH-SY5Y cells.
- Comp-23 restored movement abnormality in PD model rats.
- Comp-23 reduced infarct size in stroke model rats.
- Comp-23's protective activity was stronger than that of previously identified compound B.
Takeaway
A new compound called comp-23 helps protect brain cells from damage in diseases like Parkinson's and stroke, making it a potential treatment.
Methodology
The study involved screening compounds that bind to DJ-1 and testing their effects on cell death in cultured cells and animal models of Parkinson's disease and stroke.
Limitations
The study primarily focuses on one compound and its effects, which may not generalize to other compounds or conditions.
Participant Demographics
Male Wistar rats and C57BL/6 mice were used in the study.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website